Skip to content
  • About us
  • For advertising
  • For authors
  • Publishing ethics
  • Contacts
  • GDPR
  • български
Shopping Cart 0
Facebook
GPNews
  • Home
  • IssuesExpand
    • 2025
    • 2024
    • 2023
    • 2022
  • Article summariesExpand
    • AG and Neonatology
    • Allergology
    • Dental Health
    • Cardiology
    • Dermatology and Cosmetics
    • Endocrinology
    • From the Practice
    • Gastroenterology
    • History Teaches
    • In the World of Viruses
    • Nature Teaches
    • Neurology and Psychiatry
    • Nutrition, Dietetics, Metabolism
    • Oncology
    • Ophtalmology
    • Others
    • Otorhinolaryngology and Pulmonary Diseases
    • Pediatrics
    • Rheumatology and Diseases of the Joints
    • Test on a Clinical Case
    • Urology and Nephrology
  • Subscription
Shopping Cart 0
Facebook

  • български

GPNews
Home / Cardiology / Current strategies in lipid- lowering therapy in patients at high/very high cardiovascular risk

Current strategies in lipid- lowering therapy in patients at high/very high cardiovascular risk

отGP News публикувано на 27.05.202401.03.2025 Cardiology
стратегии в липидо-понижаващата терапия

Issue 5/2024

Savova, R., Borizanova, A., Krastev, B., Kinova, E., Gudev, A.
Clinc of Cardiology at UMHAT “ Qeen Joanna – ISUL ”, Medical University – Sofia

Prevention of atherosclerotic cardiovascular disease (ASCVD) in a given person should relate to his or her total CV risk: the higher the risk, the more intense the action should be. The new revised concepts of the recommendations of the European Society of Cardiology (ESC) from 2019 are for a more intensive reduction of LDL-cholesterol in all categories of cardiovascular risk. After experiencing an acute coronary syndrome (ACS), patients are at a high risk of suffering from recurrent ischaemic cardiovascular events, especially in the very early phase. Low density lipoprotein-cholesterol (LDL-C) is causally involved in atherosclerosis and a clear, monotonic relationship between pharmacologic LDL-C lowering and a reduction in cardiovascular events post-ACS has been shown, a concept termed „the lower, the better“. Another new one strategy, is the initiation of a combined and highly intensified lipid-lowering therapy in the early phase of ACS, known as „strike early and strike strong“.

Key words: atherosclerotic cardiovascular disease, low-density lipoprotein cholesterol (LDL-C), acute coronary syndrome (ACS), proprotein convertase subtilisin/kexin type 9 – PCSK9 inhibitor, coronary artery disease (CAD), lipid-lowering therapy (LLT), myocardial infarction (MI), European Society of Cardiology (ESC)

Address for correspondence:
Savova, R., Borizanova, A. 
Clinc of Cardiology at UMHAT “Qeen Joanna – ISUL”,
Medical University – Sofia 
8, Bialo more, Str.
1527, Sofia
e-mail: rumenasavova@gmail.com 
borizanowa@abv.bg

Post navigation

Previous Previous
Secondary involvement of the cardiovascular system in various diseases – from normal adaptation to pathological changes
NextContinue
Atrial cardiomyopathy – definition, gender differences and imaging methods for diagnosis
Search
корица 12
All issues in 2023

Issue 12/2023

PULMONOLOGY Current guidelines for the diagnosis and treatment of COPD Yordanov, P., Dimitrova, V. The point of bronchial hyperreactivity (BHR)…

Корица - 112023
All issues in 2023

Issue 11/2023

Ear / Nose / Throat Allergic rhinitis – a risk factor for asthma Perenovska, P. Phenotypes of non allergic rhinitis…

корица 10
All issues in 2023

Issue 10/2023

Endocrinology Carcinogenic risk in obesity and diabetes mellitus Karamfilova, V., Nedeva, I. Anthropometric studies on the effect of yogurt fermented…

fb like

About us

GPNews magazine
A peer of the GP practice in our country
The only specialized edition for general practitioners
12 monthly booklets on topics vital to your practice

Menu

  • Home
  • About us
  • Contact us

Information

  • For authors
  • Publishing ethics
  • For advertising

Copyright © 2025 GPNews. All rights reserved.

Web design and SEO by Tribest

  • GDPR
Scroll to top
  • Home
  • Issues
    • 2025
    • 2024
    • 2023
    • 2022
  • Article summaries
    • AG and Neonatology
    • Allergology
    • Dental Health
    • Cardiology
    • Dermatology and Cosmetics
    • Endocrinology
    • From the Practice
    • Gastroenterology
    • History Teaches
    • In the World of Viruses
    • Nature Teaches
    • Neurology and Psychiatry
    • Nutrition, Dietetics, Metabolism
    • Oncology
    • Ophtalmology
    • Others
    • Otorhinolaryngology and Pulmonary Diseases
    • Pediatrics
    • Rheumatology and Diseases of the Joints
    • Test on a Clinical Case
    • Urology and Nephrology
  • Subscription
  • About us
  • For advertising
  • For authors
  • Publishing ethics
  • Contacts
  • GDPR
Search